Abstract:Background information. Phenotype analysis has demonstrated that AQP3 (aquaporin 3) null mice are polyuric and manifest a urinary concentration defect. In the present study, we report that deletion of AQP3 is also associated with an increased urinary sodium excretion. To investigate further the mechanism of the decreased urinary concentration and significant natriuresis, we examined the segmental and subcellular localization of collecting duct AQPs [AQP2, p-AQP2 (phosphorylated AQP2), AQP3 and AQP4], ENaC (epithelial sodium channel) subunits and Na,K-ATPase by immunoperoxidase and immunofluorescence microscopy in AQP3 null (-/-), heterozygous (+/-) mice, wild-type and unrelated strain of normal mice. Results. The present study confirms that AQP3 null mice exhibit severe polyuria and polydipsia and demonstrated that they exhibit increased urinary sodium excretion. In AQP3 null mice, there is a marked down-regulation of AQP2 and p-AQP2 both in CNT (connecting tubule) and CCD (cortical collecting duct). Moreover, AQP4 is virtually absent from CNT and CCD in AQP3 null mice. Basolateral AQP2 was virtually absent from AQP3 null mice and normal mice in contrast with rat. Thus the above results demonstrate that no basolateral AQPs are expressed in CNT and CCD of AQP3 null mice. However, in the medullary-collecting ducts, there is no difference in the expression levels and subcellular localization of AQP2, p-AQP2 and AQP4 between AQP3 +/- and AQP3 null mice. Moreover, a striking decrease in the immunolabelling of the alpha 1 subunit of Na,K-ATPase was observed in CCD in AQP3 null mice, whereas a medullary-collecting duct exhibited normal labelling. Immunolabelling of all the ENaC subunits in the collecting duct was comparable between the two groups. Conclusions. The results improve the possibility that the severe urinary concentrating defect in AQP3 null mice may in part be caused by the decreased expression of AQP2, p-AQP2 and AQP4 in CNT and CCD, whereas the increased urinary sodium excretion may in part be accounted for by Na,K-ATPase in CCD in AQP3 null mice.

Aquaporin gene delivery to kidney

Partial Correction of the Urinary Concentrating Defect in Aquaporin-1 Null Mice by Adenovirus-Mediated Gene Delivery.

Nephrogenic Diabetes Insipidus in Mice Lacking Aquaporin-3 Water Channels

Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion.

Hsp90 Inhibitor Partially Corrects Nephrogenic Diabetes Insipidus In A Conditional Knock-In Mouse Model Of Aquaporin-2 Mutation

Decreased expression of AQP2 and AQP4 water channels and Na,K-ATPase in kidney collecting duct in AQP3 null mice.

Urea and Urine Concentrating Ability in Mice Lacking AQP1 and AQP3

Phenotype Analysis of Aquaporin-8 Null Mice.

Urea and Urine Concentrating Ability in Mice Lacking AQP3

Aquaporins In Renal Diseases

Aquaporin-3 Deletion in Mice Results in Renal Collecting Duct Abnormalities and Worsens Ischemia-Reperfusion Injury.

Aquaporins As Potential Drug Targets

Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene.

Increased Lung Ischemia–Reperfusion Injury in Aquaporin 1–null Mice is Mediated Via Decreased Hypoxia-Inducible Factor 2α Stability

The Human Aquaporin Gene Family

Expression and regulation of aquaporins in cystic epithelial cells of mice with polycystic kidney disease

Aquaporin‐3 Deficiency Slows Cyst Enlargement in Experimental Mouse Models of Autosomal Dominant Polycystic Kidney Disease

Aquaporin-1 deletion in mice inhibits hepa1-6 hepatocellular carcinoma growth

AQP1 in the Gastrointestinal Tract of Mice: Expression Pattern and Impact of AQP1 Knockout on Colonic Function

Upregulation of Urea Transporter UT-A2 and Water Channels AQP2 and AQP3 in Mice Lacking Urea Transporter UT-B

Possible Role of AQP3 in the Concentration of Non‐urea Solutes in Urine